Close Menu

NEW YORK (GenomeWeb News) – Vermillion reported after the close of the market Wednesday that its fourth-quarter revenues increased 32 percent to $1.1 million from $868,000, beating the consensus Wall Street estimate for revenues of $900,000.

The firm's product sales were $1 million for the three months ended Dec. 31, 2012, compared to $755,000 for the fourth quarter of 2011. License revenues were flat year over year at $113,000.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.